Evidence map›Paper›PMID 30549147›Full record

ArticleHead & neck2019

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.

Sarah Schimansky, Samantha Lang, Rhona Beynon, Christopher Penfold, Amy Davies, Andrea Waylen, Steve Thomas, Miranda Pring, Michael Pawlita, Tim Waterboer and 1 more

Abstract read
In one paragraph

Article in Head & neck, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Cancer epidemiology literature from India: Does it reflect the reality?Journal of public health (Oxford, England) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah SchimanskyNational Institute of Health (NIHR) Bristol Biomedical Research Centre, Nutrition Theme, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-7539-2104
Samantha LangNational Institute of Health (NIHR) Bristol Biomedical Research Centre, Nutrition Theme, University of Bristol, Bristol, United Kingdom.ORCID 0000-0001-8662-6386
Rhona BeynonDepartment of Population Health Sciences, University of Bristol Medical School, Bristol, United Kingdom.
Christopher PenfoldNational Institute of Health (NIHR) Bristol Biomedical Research Centre, Nutrition Theme, University of Bristol, Bristol, United Kingdom.ORCID 0000-0001-8654-353X
Amy DaviesNational Institute of Health (NIHR) Bristol Biomedical Research Centre, Nutrition Theme, University of Bristol, Bristol, United Kingdom.
Andrea WaylenDepartment of Oral and Dental Sciences, Bristol Dental School, Bristol, United Kingdom.
Steve ThomasDepartment of Oral and Dental Sciences, Bristol Dental School, Bristol, United Kingdom.
Miranda PringDepartment of Oral and Dental Sciences, Bristol Dental School, Bristol, United Kingdom.
Michael PawlitaMolecular Diagnostics of Oncogenic Infections Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tim WaterboerInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andy NessNational Institute of Health (NIHR) Bristol Biomedical Research Centre, Nutrition Theme, University of Bristol, Bristol, United Kingdom.

Funding

Cancer Research UK 19169Cancer Research UK C18281/A19169Department of Health RP-PG-0707-10034Wellcome TrustWellcome Trust 110021/z/15/A
6 · The paper itself

Abstract

backgroundPeople with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.

methodsSurvival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.

resultsAfter adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).

conclusionsOur findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.

Indexed as

ComorbidityOutcome Assessment, Health CareAdultAgedAge DistributionCarcinoma, Squamous CellCause of DeathCohort StudiesDatabases, FactualFemaleHead and Neck NeoplasmsHumansIncidenceKaplan-Meier EstimateMaleMiddle AgedACE 27comorbidityhead and neck cancerhuman papillomavirussurvival

Identifiers

PMID30549147
PMCPMC6890487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.